These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 696756)

  • 1. Hospitals defend formulary decisions against industry attacks.
    Talley CR
    Am J Hosp Pharm; 1978 Sep; 35(9):1154-5. PubMed ID: 696756
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacoeconomic analysis in formulary decisions: an international perspective.
    Johnson JA; Bootman JL
    Am J Hosp Pharm; 1994 Oct; 51(20):2593-8. PubMed ID: 7847423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When the pharmacy and therapeutics committee decides.
    Garrison TJ
    Hosp Pharm; 1979 Sep; 14(9):506-7. PubMed ID: 10243912
    [No Abstract]   [Full Text] [Related]  

  • 4. Survey of formulary system policies and procedures.
    Rascati KL
    Am J Hosp Pharm; 1992 Jan; 49(1):100-3. PubMed ID: 1570847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving pharmacy and therapeutics committee operations.
    Cohen MR; Klapp D; Miller KB; Shaffer VL; Slotfeldt M; Miller DE
    Am J Hosp Pharm; 1984 Sep; 41(9):1767-77. PubMed ID: 6496511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The formulary system: product of the teaching hospital.
    Francke DE
    Hospitals; 1967 Nov; 41(22):110 passim. PubMed ID: 6062395
    [No Abstract]   [Full Text] [Related]  

  • 7. The other side of the fence: hospital P&T committee members' role in drug selection.
    Archambault GF
    Med Mark Media; 1978 May; 13(5):48, 50, 52 passim. PubMed ID: 10307029
    [No Abstract]   [Full Text] [Related]  

  • 8. A survey of selective administration procedures in formulary maintenance.
    Quigley MA; Brown WM
    Hosp Pharm; 1981 Jul; 15(7):371-4, 378-80. PubMed ID: 10252001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P & T Committee formulary requests: criteria for admission.
    Weintraub M; Guttmacher L
    Hosp Formul; 1984 Oct; 19(10):975-7, 980. PubMed ID: 10268315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion of innovation I: Formulary acceptance rates of new drugs in teaching and non-teaching British Columbia hospitals--a hospital pharmacy perspective.
    D'Sa MM; Hill DS; Stratton TP
    Can J Hosp Pharm; 1994 Dec; 47(6):254-60. PubMed ID: 10139270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to crack the $2 billion hospital market for pharmaceuticals.
    Zellmer WA
    Med Mark Media; 1981 May; 16(5):16, 24. PubMed ID: 10251527
    [No Abstract]   [Full Text] [Related]  

  • 12. Formulary management to reduce cost: P & T committee strategies.
    Roberts MJ; Summerfield MR
    Hosp Formul; 1986 Apr; 21(4):481-3, 488-92. PubMed ID: 10276289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges of a P & T Committee in a community teaching hospital.
    Cooke DH; Kessler J
    Hosp Formul; 1990 Aug; 25(8):878-82, 886. PubMed ID: 10105706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An inside look at the UCLA P&T committee: how does it influence prescribing practices?
    Conolly ME
    Hosp Formul; 1986 Feb; 21(2):214-7. PubMed ID: 10275576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulary status of intravenous immunoglobulins in selected hospitals.
    Hatton RC; Doering PL; Fakhoury M; Williams RB
    Am J Hosp Pharm; 1988 Nov; 45(11):2377-9. PubMed ID: 3228096
    [No Abstract]   [Full Text] [Related]  

  • 16. P & T committees and the hospital formulary.
    Evans PJ; Standish RC; Bell JE
    Hosp Formul; 1983 Sep; 18(9):892-5. PubMed ID: 10262367
    [No Abstract]   [Full Text] [Related]  

  • 17. Formulary decision making: identifying factors that influence P&T committee drug evaluations.
    Segal R; Pathak DS
    Hosp Formul; 1988 Feb; 23(2):174-8. PubMed ID: 10286022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Achieving an effective committee through reorganization: the Ohio State University Hospital's experience.
    Lewis RP; Moore TD
    Hosp Formul; 1991 Feb; 26(2):120-30. PubMed ID: 10109143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementing and maintaining a viable formulary.
    Kelly WN; Bender FH
    Hosp Formul; 1983 Oct; 18(10):976-8, 981-2, 987. PubMed ID: 10262828
    [No Abstract]   [Full Text] [Related]  

  • 20. The foremost problems associated with formulary management.
    Davis NM
    Hosp Pharm; 1983 Mar; 18(3):131, 134-5. PubMed ID: 10260204
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.